Identification of prognostic markers in diffuse midline gliomas H3K27M‐mutant
Charlotte Dufour(Institut de Biologie de Lille), Florence Renaud(Inserm), Romain Vasseur(Inserm), Romain Perbet, Nicolas Reyns(Centre National de la Recherche Scientifique), Matthieu Vinchon(Université Claude Bernard Lyon 1), Laurence Stechly(Institut de Biologie de Lille), Adeline Piérache(Université de Lille), Émilie Le Rhun(University of Zurich), Fabienne Escande(Université de Lille), Gustavo Touzet(Hôpital Roger Salengro), Pierre Leblond(Centre Oscar Lambret), Claude‐Alain Maurage(Centre Hospitalier Universitaire de Lille)
Cited by 41
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994